ArticlePharmacoEconomics - open2017

Economic Evaluation of Fulvestrant 500 mg Compared to Generic Aromatase Inhibitors in Patients with Advanced Breast Cancer in Sweden.

Ugne Sabale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.